Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT
Sponsor: Ministry of Health, Labor and Welfare (Japan)
A NA clinical study on Impaired Glucose Tolerance and Myocardial Infarction, this trial is terminated or withdrawn. The trial is conducted by Ministry of Health, Labor and Welfare (Japan) and has accumulated 7 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2023 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Nov 2023 [monthly]
Terminated NA
-
Sep 2018 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Health, Labor and Welfare (Japan)
- National Cerebral and Cardiovascular Center, Japan
For direct contact, visit the study record on ClinicalTrials.gov .